GSE168284
MicroRNA expression differences in blood-derived CD19+ B cells of methotrexate treated rheumatoid arthritis patients
The aims of the study were to assess the global miRNA repertoire of peripheral blood CD19+ B cells, by high throughput sequencing, and to uncover miRNA expression differences between RA patients (newly-diagnosed and methotrexate treated) and healthy controls.   Overall design: Newly-diagnosed rheumatoid arthritis patients (n=10), methotrexate treated rheumatoid arthritis patients (n=18), healthy controls (n=9),